Multiple Sclerosis (MS) Patients with Emotionality
If you or someone you know experience episodes of uncontrollable
laughing and/or crying, you may be eligible for a clinical study now
underway to find a treatment for this condition.
A clinical research trial is actively enrolling patients to evaluate
the efficacy and safety of a targeted treatment known as AVP-923. The
study is recruiting patients with MS or other neurological disorders
who also have pseudobulbar affect, a condition characterized by
episodes of uncontrollable laughing and/or crying. An estimated 10
percent of MS patients suffer from pseudobulbar affect.
To determine if you or someone you know is eligible for one of the
studies, please call Coordinated Clinical Research at 858-455-5463.
Participants Must:
- Be between 18 and 80 years of age
- Meet all trial criteria
You can sign up for this trial here!
|